Table 1. Detection in 17 patients suggestive of LFS of 21 germline CNVs not recorded in the DGV.
Cytoband | CNV coordinates (hg18)a | CNV type | Protein-coding genes and microRNAs involvedb | CNV size (kb) | Patient ID | |
---|---|---|---|---|---|---|
1 | p36.12 | chr1:23244421–23562102 | del | KDM1A (part), LUZP1, HTR1D, HNRNPR, ZNF436 (part) | 318 | 53 |
1 | q41 | chr1:218356562–218359749 | del | IARS2 (part), MIR215, MIR194-1 | 4 | 16, 57 |
2 | p21 | chr2:42591803–42763199 | dup | MTA3 (part) | 172 | 33 |
2 | p15 | chr2:61978338–62094667 | del | COMMD1 (part) | 116 | 14 |
3 | p14.1 | chr3:65642102–65889226 | del | MAGI1 (part) | 248 | 53 |
3 | q13.13 | chr3:110094154–110495138 | dup | GUCA1C, MORC1, DPPA2 (part) | 401 | 53 |
3 | q29 | chr3:198768821–198969885 | dup | BDH1 (part), KIAA0226, MIR922, FYTTD1 (part) | 201 | 6 |
4 | q32.2 | chr4:162313725–162948651 | dup | FSTL5 (part) | 635 | 17 |
5 | p13.3 | chr5:34024123–34126697 | del | AMACR, C1QTNF3 | 103 | 2 |
5 | q13.2 | chr5:68405282–68519258 | del | SLC30A5, CCNB1 | 114 | 38 |
5 | q14.1 | chr5:79525024–79740886 | dup | SERINC5 (part), SPZ1, ZFYVE16 (part) | 216 | 38 |
6 | p21.31 | chr6:34977196–35058894 | del | ANKS1A (part) | 82 | 60 |
6 | p12.3 | chr6:47509689–47664601 | del | CD2AP (part) | 155 | 27 |
6 | q14.1 | chr6:80910016–81553302 | dup | BCKDHB (part) | 642 | 5 |
7 | q22.1 | chr7:98286465–98454581 | dup | TMEM130 (part), TRRAP | 169 | 63 |
9 | q22.32 | chr9:96591859–96705414 | del | C9orf3 (part) | 114 | 55 |
11 | p15.5 | chr11:200300–332720 c | dup | RIC8A, SIRT3, PSMD13, NLRP6, ATHL1, IFITM5, IFITM2, IFITM1, IFITM3 | 133 | 17 |
11 | p13 | chr11:32989228–33445279 | dup | DEPDC7, TCP11L1, CSTF3, HIPK3 | 456 | 24 |
11 | q13.2 | chr11:68358122–68452839 | dup | CPT1A (part), MRPL21, IGHMBP2 (part) | 95 | 33 |
21 | q22.3 | chr21:42945519–43196797 | dup | PDE9A, WDR4, NDUFV3 (part) | 252 | 54 |
X | q13.1 | chrX:71771657–71876745 | dup | PHKA1 (part) | 105 | 19 |
Abbreviations: CNV, copy number variation; DGV, Database of Genomic Variants; del, deletion; dup, duplication; LFS, Li-Fraumeni syndrome; part, partial rearrangement of the gene.
Defined according to the genomic positions of the first oligonucleotides of the first and last deviated probes, respectively.
Genes in bold are involved in chromatin remodelling.
On chromosome 11, the first telomeric probe starts on genomic position 2 00 300, consequently no information before this position is available.